DNMT3B and neoplasm: In mouse models, it has been shown that heterozygous mutations for Dnmt1 cause a global reduction in DNA methylation, which was associated with a reduced prevalence of intestinal tumors [8], whereas deletion of Dnmt3b led to reduced tumor size [9].